Translational Development Acquisition Corp.
TDAC
$10.32
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 221.10K | 347.40K | 133.40K | 61.30K | 1.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 221.10K | 347.40K | 133.40K | 61.30K | 1.70K |
| Operating Income | -221.10K | -347.40K | -133.40K | -61.30K | -1.70K |
| Income Before Tax | 1.62M | 1.48M | -8.00K | -61.30K | -1.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.62M | 1.48M | -8.00K | -61.30K | -1.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.62M | 1.48M | -8.00K | -61.30K | -1.70K |
| EBIT | -221.10K | -347.40K | -133.40K | -61.30K | -1.70K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.07 | 0.07 | 0.00 | -0.02 | 0.00 |
| Normalized Basic EPS | 0.05 | 0.04 | 0.00 | -0.01 | 0.00 |
| EPS Diluted | 0.07 | 0.07 | 0.00 | -0.02 | 0.00 |
| Normalized Diluted EPS | 0.05 | 0.04 | 0.00 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 21.91M | 21.91M | 5.42M | 4.05M | 4.05M |
| Average Diluted Shares Outstanding | 21.91M | 21.91M | 5.42M | 4.05M | 4.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |